Showing results (521-530 of 2,511) with videos related to

Sort By:
Pageof 252
Inflammopharmacology|August 21, 2024
Brain resident microglia in Alzheimer's disease: foe or friendsSimranjit Kaur, Malleshwari K, Anamika Sharma, et al.
Inflammopharmacology|August 19, 2024
Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implicationsAbhishek Satheesan, Janardanan Kumar, Kakithakara Vajravelu Leela, et al.
Inflammopharmacology|August 13, 2024
Unraveling neuroprotection in Parkinson's disease: Nrf2-Keap1 pathway's vital role amidst pathogenic pathwaysTanzeer Kaur, Palak Sidana, Navpreet Kaur, et al.
Inflammopharmacology|August 21, 2024
Exploring the efficacy and safety of cannabidiol in individuals with epilepsy: an umbrella review of meta-analyses and systematic reviewsHamid Abbasi, Mohammad Mehdi Abbasi, Mohammadjavad Pasand, et al.
Inflammopharmacology|August 21, 2024
Neutrophil-lymphocyte ratio and systemic immune-inflammation index as predictors of cardiovascular risk and mortality in prediabetes and diabetes: a population-based studyXiaoli Chen, Aihua Li, Qilin Ma
Inflammopharmacology|August 10, 2024
The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer's diseaseChangQing Li, Xun Zhang, Yunqian Wang, et al.
Inflammopharmacology|August 12, 2024
Wound healing potential and anti-inflammatory action of extracts and compounds of Myrciaria plinioides D. Legrand leavesDiorge Jônatas Marmitt, Gabriela Vettorazzi, Luísa Bortoluzzi, et al.
Inflammopharmacology|August 10, 2024
Apigenin and inflammation in the brain: can apigenin inhibit neuroinflammation in preclinical models?Tosin A Olasehinde, Oyinlola O Olaokun
Inflammopharmacology|August 11, 2024
Preclinical efficacy of oral and nasal rivastigmine-loaded chitosan nano-particles on AlCl3-induced Alzheimer's-like disease in ratsDina E ElMosbah, Marwa S Khattab, Marwa A Ibrahim, et al.
Inflammopharmacology|August 11, 2024
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysisZiqin Cao, Qiangxiang Li, Jianhuang Wu, et al.
Pageof 252